N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide

C29H26N4O2S — CID 19058793

IUPACN-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide
SMILESCC(C)c1ccc(/C=C2\N=C(SCC(=O)Nc3ccc4cc[nH]c4c3)N(c3ccccc3)C2=O)cc1
InChIInChI=1S/C29H26N4O2S/c1-19(2)21-10-8-20(9-11-21)16-26-28(35)33(24-6-4-3-5-7-24)29(32-26)36-18-27(34)31-23-13-12-22-14-15-30-25(22)17-23/h3-17,19,30H,18H2,1-2H3,(H,31,34)/b26-16-
InChIKeyASJTVGMCZHBNGY-QQXSKIMKSA-N
MW494.62 g/mol
LogP6.41
Rot. Bonds6

About N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide

N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide (PubChem CID 19058793) has the molecular formula C29H26N4O2S and a molecular weight of 494.62 g/mol. Its IUPAC name is N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide.

Molecular Properties

Compound NameN-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide
PubChem CID19058793
Molecular FormulaC29H26N4O2S
Molecular Weight494.62 g/mol
Exact Mass494.18
IUPAC NameN-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide
SMILESCC(C)c1ccc(/C=C2\N=C(SCC(=O)Nc3ccc4cc[nH]c4c3)N(c3ccccc3)C2=O)cc1
InChIInChI=1S/C29H26N4O2S/c1-19(2)21-10-8-20(9-11-21)16-26-28(35)33(24-6-4-3-5-7-24)29(32-26)36-18-27(34)31-23-13-12-22-14-15-30-25(22)17-23/h3-17,19,30H,18H2,1-2H3,(H,31,34)/b26-16-
InChIKeyASJTVGMCZHBNGY-QQXSKIMKSA-N
XLogP6.41
TPSA77.56 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500494.62
LogP ≤ 56.41
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
The IUPAC name of N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide (CID 19058793) is N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide.
What is the SMILES notation for N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
The canonical SMILES for N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide is CC(C)c1ccc(/C=C2\N=C(SCC(=O)Nc3ccc4cc[nH]c4c3)N(c3ccccc3)C2=O)cc1.
What is the InChIKey of N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
The InChIKey is ASJTVGMCZHBNGY-QQXSKIMKSA-N. The full InChI is InChI=1S/C29H26N4O2S/c1-19(2)21-10-8-20(9-11-21)16-26-28(35)33(24-6-4-3-5-7-24)29(32-26)36-18-27(34)31-23-13-12-22-14-15-30-25(22)17-23/h3-17,19,30H,18H2,1-2H3,(H,31,34)/b26-16-.
What are the key properties of N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide?
N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide has a molecular weight of 494.62 g/mol, XLogP of 6.41, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1H-indol-6-yl)-2-[(4Z)-5-oxo-1-phenyl-4-[(4-propan-2-ylphenyl)methylidene]imidazol-2-yl]sulfanylacetamide is sourced from PubChem (CID 19058793), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).